The DEA telehealth extension: how to prepare for new patient identity verification requirements
On December 31, 2025, the DEA issued its fourth temporary extension of the COVID-era telemedicine flexibilities, keeping the current rules in place through December 31, 2026. For telehealth companies prescribing controlled substances, the extension was welcome news.